Better pharmaceutical design should lead to improved therapeutic performance.
Editorial proposition
JPBS is a peer-reviewed pharmaceutical-science journal for research in formulation, drug delivery, pharmaceutical technology and biopharmaceutics.
The journal therefore seeks to publish research that goes beyond the development or characterisation of a pharmaceutical formulation and demonstrates the impact of pharmaceutical design. Studies are of particular interest when they show how formulation and drug-delivery strategies influence drug stability, solubility, dissolution, permeability, bioavailability, targeting, pharmacokinetics, efficacy, safety or other clinically relevant properties.
How we read a study
We look for a clear line of sight from pharmaceutical design to biological or therapeutic performance—not three disconnected claims.
JPBS covers both established and emerging approaches in the pharmaceutical sciences, including conventional and advanced dosage forms, controlled and targeted drug delivery, nanopharmaceuticals, pharmaceutical nanotechnology, natural-product formulations, biologics, pharmaceutical biotechnology, and other technologies that enhance the performance of therapeutic agents.
A defining feature of the journal is the link between pharmaceutical development and biological or therapeutic outcomes. Biological, pharmacological, microbiological, molecular or preclinical investigations are considered when they are directly relevant to the development, evaluation, mechanism or therapeutic performance of a pharmaceutical product or delivery system.
The journal particularly values research that follows a clear path: pharmaceutical design, then formulation or delivery, then biological performance, then therapeutic relevance. That emphasis distinguishes JPBS from journals that focus exclusively on formulation development or, conversely, on biomedical investigation that lacks a substantive pharmaceutical component.
Editorial focus
JPBS gives particular consideration to research that can clearly answer one or more of the following questions:
Through this focused editorial approach, JPBS seeks to promote pharmaceutical research that moves from formulation design to functional performance and, ultimately, toward therapeutic impact.
